The mRNA's market is presently experiencing significant growth, fueled by the successful deployment of mRNA-based immunizations against COVID-19. Studies reveal a complex landscape, with ongoing capital into therapeutic applications separate from infectious diseases, covering areas such as oncology, rare diseases, and protein replacement care. A… Read More